Cataract as a Protein-Aggregation Disease

Protein Misfolding Diseases: Current and Emerging Principles and Therapies

Volumn , Issue , 2010, Pages 487-515

  Wang, Yongting ^a   King, Jonathan A ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

cataract, protein aggregation disease affecting vision in humans, as lens cataract; Cataracts, unusual among protein deposition diseases direct relationship, between pathology lens opacity and loss of sight; Loss of transparency and light scattering aggregated states of major lens crystallins and disruption of lens fiber architecture

Indexed keywords

EID: 81355156480     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470572702.ch22     Document Type: Chapter

References (194)

1. Vision Problems in the U.S.: Prevalence of Adult Vision Impairment and Age-Related Eye Disease in America, published in conjunction with the National Eye Institute, Prevent Blindness America 2000, 38 pp.
2. Oyster, C. W. (1999). The Human Eye: Structure and Function, Sinauer Associates, Sunderland, MA.
3. Delaye, M., Tardieu, A. (1983). Short-range order of crystallin proteins accounts for eye lens transparency. Nature, 302, 415-417.
4. Hamai, Y., Fukui, H. N., Kuwabara, T. (1974). Morphology of hereditary mouse cataract. Exp Eye Res, 18, 537-546.
5. Hamai, Y., Kuwabara, T. (1975). Early cytologic changes of Fraser cataract: an electron microscopic study. Invest Ophthalmol, 14, 517-527.
6. Metlapally, S., Costello, M. J., Gilliland, K. O., Ramamurthy, B., Krishna, P. V., Balasubramanian, D., Johnsen, S. (2007). Analysis of nuclear fiber cell cytoplasmic texture in advanced cataractous lenses from Indian subjects using Debye-Bueche theory. Exp Eye Res, 86, 434-444.
7. Pande, A., Pande, J., Asherie, N., Lomakin, A., Ogun, O., King, J. A., Lubsen, N. H., Walton, D., Benedek, G. B. (2000). Molecular basis of a progressive juvenile-onset hereditary cataract. Proc Natl Acad Sci U S A, 97, 1993-1998.
8. Pande, A., Pande, J., Asherie, N., Lomakin, A., Ogun, O., King, J., Benedek, G. B. (2001). Crystal cataracts: human genetic cataract caused by protein crystallization. Proc Natl Acad Sci U S A, 98, 6116-6120.
9. Kmoch, S.,Brynda, J.,Asfaw,B.,Bezouska,K.,Novak, P., Rezacova, P., Ondrova, L., Filipec, M., Sedlacek, J., Elleder, M. (2000). Link between a novel human gammaDcrystallin allele and a unique cataract phenotype explained by protein crystallography. Hum Mol Genet, 9, 1779-1786.
10. Bellows, J. E. (1975). Cataracts and Abnormalities of the Lens, Grune & Stratton, New York.
11. Clark, J. (1994). Principle and Practice of Opthamology, Saunders College Publishing, Philadelphia.
12. Hanson, S. R., Hasan, A., Smith, D. L., Smith, J. B. (2000). The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp Eye Res, 71, 195-207.
13. Benedek, G. (1997). Cataract as a protein condensation disease: the Proctor Lecture. Invest Ophthalmol Vis Sci, 38, 1911-1921.
14. Mitraki, A., King, J. (1989). Protein folding intermediates and inclusion body formation. Biotechnology, 7, 690-697.
15. Wetzel, R. (1994). Mutations and off-pathway aggregation of proteins. Trends Biotechnol, 12, 193-198.
16. Betts, S., King, J. (1999). There's a right way and a wrong way: in vivo and in vitro folding, misfolding and subunit assembly of the P22 tailspike. Structure, 7, R131-R139.
17. Smith, J. B., Sun, Y., Smith, D. L., Green, B. (1992). Identification of the posttranslational modifications of bovine lens alpha B-crystallins by mass spectrometry. Protein Sci, 1, 601-608.
18. Lapko, V. N., Smith, D. L., Smith, J. B. (2003). Methylation and carbamylation of human gamma-crystallins. Protein Sci, 12, 1762-1774.
19. Slingsby, C., Clout, N. J. (1999). Structure of the crystallins. Eye, 13(Pt 3b), 395-402.
20. Lampi,K. J.,Ma, Z.,Hanson, S. R.,Azuma,M., Shih,M., Shearer,T. R., Smith,D.L., Smith, J. B., David, L. L. (1998). Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry. Exp Eye Res, 67, 31-43.
21. Chiti, F., Dobson, C. M. (2006). Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem, 75, 333-366.
22. Speed, M., Wang, D., King, J. (1995). Multimeric intermediates in the pathway to the aggregated inclusion body state for P22 tailspike polypeptide chains. Protein Sci 4, 900-908.
23. Wetzel, R. (1996). For protein misassembly, it's the "I" decade. Cell, 86, 699-702.
24. Lund, A. L., Smith, J. B., Smith, D. L. (1996). Modifications of the water-insoluble human lens alpha-crystallins. Exp Eye Res, 63, 661-672.
25. Miesbauer, L. R., Zhou, X., Yang, Z., Yang, Z., Sun, Y., Smith, D. L., Smith, J. B. (1994). Post-translational modifications of water-soluble human lens crystallins from young adults. J Biol Chem, 269, 12494-12502.
26. MacCoss, M., McDonald, W., Saraf, A., Sadygov, R., Clark, J., Tasto, J., Gould, K., Wolters, D., Washburn, M., Weiss, A., et al. (2002). Shotgun identification of protein modifications from protein complexes and lens tissue. Proc Natl Acad Sci U S A, 99, 7900-7905.
27. Ma, Z., Hanson, S. R., Lampi, K. J., David, L. L., Smith, D. L., Smith, J. B. (1998). Age-related changes in human lens crystallins identified by HPLC and mass spectrometry. Exp Eye Res, 67, 21-30.
28. Frederikse, P. (2000). Amyloid-like protein structure in mammalian ocular lens. Curr Eye Res, 20, 462-468.
29. Meehan, S., Berry, Y., Luisi, B., Dobson, C. M., Carver, J. A., MacPhee, C. E. (2004). Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation. J Biol Chem, 279, 3413-3419.
30. Papanikolopoulou, K., Mills-Henry, I., Thol, S. L., Wang, Y., Gross, A. A.R., Kirschner, D. A., Decatur, S. M., King, J. (2008). Formation of amyloid fibrils in vitro by human gD-crystallin and its isolated domains. Mol Vis, 14, 81-89.
31. Kosinski-Collins, M. S., King, J. (2003). In vitro unfolding, refolding, and polymerization of human gammaD crystallin, a protein involved in cataract formation. Protein Sci, 12, 480-490.
32. Hollows, F., Moran, D. (1981). Cataract: the ultraviolet risk factor. Lancet, 2, 1249-1250.
33. Taylor, H. R., West, S. K., Rosenthal, F. S., Munoz, B., Newland, H. S., Abbey, H., Emmett, E. A. (1988). Effect of ultraviolet radiation on cataract formation. N Engl J Med, 319, 1429-1433.
34. McCarty, C. A., Taylor, H. R. (2002). A review of the epidemiologic evidence linking ultraviolet radiation and cataracts. Dev Ophthalmol, 35, 21-31.
35. Sasaki, H., Jonasson, F., Shui,Y. B., Kojima, M., Ono, M., Katoh, N., Cheng, H. M., Takahashi, N., Sasaki, K. (2002). High prevalence of nuclear cataract in the population of tropical and subtropical areas. Dev Ophthalmol, 35, 60-69.
36. Lerman, S. (1962). Radiation cataractogenesis. N Y State J Med, 62, 3075-3085.
37. Hannah, C. (1975). Cataract of toxic etiology, In Cataracts and Abnormalities of the Lens (Bellows, J. G., (Ed.), Grune & Stratton, New York.
38. Wolbarsht,M.L., Orr,M.A.,Yamanashi, B. S., Zigler, J. S., Matheson, I. B.C. (1977). The Origin of Cataracts in the Lens from Infrared Laser Radiation: Annual Progress Report, U.S. ArmyMedical Research and DevelopmentCommand, Washington, DC.
39. Lerman, S. (1980). Radiant Energy and the Eye, Macmillan, New York.
40. Giblin, F. J., Leverenz, V. R., Padgaonkar, V. A., Unakar, N. J., Dang, L., Lin, L. R., Lou, M. F., Reddy, V. N., Borchman, D., Dillon, J. P. (2002). UVA light in vivo reaches the nucleus of the guinea pig lens and produces deleterious, oxidative effects. Exp Eye Res, 75, 445-458.
41. Sliney, D. H. (2002). How light reaches the eye and its components. Int J Toxicol, 21, 501-509.
42. Soderberg, P. G., Lofgren, S., Ayala, M., Dong, X., Kakar, M., Mody, V. (2002). Toxicity of ultraviolet radiation exposure to the lens expressed by maximum tolerable dose. Dev Ophthalmol, 35, 70-75.
43. Padayatti, P. S., Ng, A. S., Uchida, K., Glomb, M. A., Nagaraj, R. H. (2001). Argpyrimidine, a blue fluorophore in human lens proteins: high levels in brunescent cataractous lenses. Invest Ophthalmol Vis Sci, 42, 1299-1304.
44. Taylor, L. M., Andrew Aquilina, J., Jamie, J. F., Truscott, R. J. (2002). UV filter instability: consequences for the human lens. Exp Eye Res, 75, 165-175.
45. Chen, J., Flaugh, S. L., Callis, P. R., King, J. (2006). Mechanism of the highly efficient quenching of tryptophan fluorescence in human gammaD-crystallin. Biochemistry, 45, 11552-11563.
46. Langley, R. K., Mortimer, C. B., McCulloch, C. (1960). The experimental production of cataracts by exposure to heat and light. Arch Ophthalmol, 63, 473-488.
47. Dillon, J., Skonieczna, M., Mandal, K., Paik, D. (1999). The photochemical attachment of the O-glucoside of 3-hydroxykynurenine to alpha-crystallin: a model for lenticular aging. Photochem Photobiol, 69, 248-253.
48. Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414, 813-820.
49. Baynes, J. W., Thorpe, S. R. (1999). Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 48, 1-9.
50. Ghahary, A., Luo, J. M., Gong, Y. W., Chakrabarti, S., Sima, A. A., Murphy, L. J. (1989). Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats. Diabetes, 38, 1067-1071.
51. Chung, S. S., Ho, E. C., Lam, K. S., Chung, S. K. (2003). Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol, 14, S233-S236.
52. Stitt, A. W. (2005). The Maillard reaction in eye diseases. Ann N Y Acad Sci, 1043, 582-597.
53. Hejtmancik, J. F. (1998). The genetics of cataract: our vision becomes clearer. Am J Hum Genet, 62, 520-525.
54. Stephan, D. A., Gillanders, E., Vanderveen, D., Freas-Lutz, D., Wistow, G., Baxevanis, A. D., Robbins, C. M., VanAuken, A., Quesenberry, M. I., Bailey-Wilson, J., et al. (1999). Progressive juvenile-onset punctate cataracts caused by mutation of the gammaD-crystallin gene. Proc Natl Acad SciUS A, 96, 1008-1012.
55. Litt, M., Kramer, P., LaMorticella, D.M., Murphey, W., Lovrien, E. W., Weleber, R. G. (1998). Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum Mol Genet, 7, 471-474.
56. Litt,M., Carrero-Valenzuela, R., LaMorticella, D.M., Schultz,D.W., Mitchell,T.N., Kramer, P., Maumenee, I. H. (1997). Autosomal dominant cerulean cataract is associated with a chain termination mutation in the human beta-crystallin gene CRYBB2. Hum Mol Genet, 6, 665-668.
57. Berry, V., Francis, P., Kaushal, S., Moore, A., Bhattacharya, S. (2000). Missense mutations in MIP underlie autosomal dominant "polymorphic" and lamellar cataracts linked to 12q. Nat Genet, 25, 15-17.
58. Shiels, A., Mackay, D., Ionides, A., Berry, V., Moore, A., Bhattacharya, S. (1998). A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q. Am J Hum Genet, 62, 526-532.
59. Mackay, D. S., Andley, U. P., Shiels, A. (2004). A missense mutation in the gammaD crystallin gene (CRYGD) associated with autosomal dominant "corallike" cataract linked to chromosome 2q. Mol Vis, 10, 155-162.
60. Nandrot, E., Slingsby, C., Basak, A., Cherif-Chefchaouni, M., Benazzouz, B., Hajaji, Y., Boutayeb, S., Gribouval, O., Arbogast, L., Berraho, A., et al. (2003). Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts. J Med Genet, 40, 262-267.
61. Santhiya, S. T., Shyam Manohar, M., Rawlley, D., Vijayalakshmi, P., Namperumalsamy, P., Gopinath, P. M., Loster, J., Graw, J. (2002). Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts. J Med Genet, 39, 352-358.
62. Shentu, X., Yao, K., Xu, W., Zheng, S., Hu, S., Gong, X. (2004). Special fasciculiform cataract caused by a mutation in the gammaD-crystallin gene. Mol Vis, 10, 233-239.
63. Heon, E., Priston, M., Schorderet, D. F., Billingsley, G. D., Girard, P. O., Lubsen, N., Munier, F. L. (1999). The gamma-crystallins and human cataracts: a puzzle made clearer. Am J Hum Genet, 65, 1261-1267.
64. Messina-Baas, O. M., Gonzalez-Huerta, L. M., Cuevas-Covarrubias, S. A. (2006). Two affected siblings with nuclear cataract associated with a novel missense mutation in the CRYGD gene. Mol Vis, 12, 995-1000.
65. Gonzalez-Huerta, L. M., Messina-Baas, O. M., Cuevas-Covarrubias, S. A. (2007). A family with autosomal dominant primary congenital cataract associated with a CRYGC mutation: evidence of clinical heterogeneity. Mol Vis, 13, 1333-1338.
66. Zhang, L. Y., Yam, G. H., Fan, D. S., Tam, P. O., Lam, D. S., Pang, C. P. (2007). A novel deletion variant of gammaD-crystallin responsible for congenital nuclear cataract. Mol Vis, 13, 2096-2104.
67. Ren, Z., Li, A., Shastry, B. S., Padma, T., Ayyagari, R., Scott, M. H., Parks, M. M., Kaiser-Kupfer, M. I., Hejtmancik, J. F. (2000). A 5-base insertion in the gammaCcrystallin gene is associated with autosomal dominant variable zonular pulverulent cataract. Hum Genet, 106, 531-537.
68. Gill, D., Klose, R., Munier, F. L., McFadden, M., Priston, M., Billingsley, G., Ducrey, N., Schorderet, D. F., Heon, E. (2000). Genetic heterogeneity of the Coppock-like cataract: a mutation in CRYBB2 on chromosome 22q11.2. Invest Ophthalmol Vis Sci, 41, 159-165.
69. Vanita, Sarhadi, V., Reis, A., Jung, M., Singh, D., Sperling, K., Singh, J. R., Burger, J. (2001). A unique form of autosomal dominant cataract explained by gene conversion between beta-crystallin B2 and its pseudogene. J Med Genet, 38, 392-396.
70. Burdon, K. P., Wirth, M. G., Mackey, D. A., Russell-Eggitt, I. M., Craig, J. E., Elder, J. E., Dickinson, J. L., Sale, M. M. (2004). A novel mutation in the connexin 46 gene causes autosomal dominant congenital cataract with incomplete penetrance. J Med Genet, 41, e106,
71. Mackay, D. S., Andley, U. P., Shiels, A. (2003). Cell death triggered by a novel mutation in the alphaA-crystallin gene underlies autosomal dominant cataract linked to chromosome 21q. Eur J Hum Genet, 11, 784-793.
72. Mackay, D. S., Boskovska, O. B., Knopf, H. L., Lampi, K. J., Shiels, A. (2002). A nonsense mutation in CRYBB1 associated with autosomal dominant cataract linked to human chromosome 22q. Am J Hum Genet, 71, 1216-1221.
73. Vicart, P., Caron, A., Guicheney, P., Li, Z., Prevost, M. C., Faure, A., Chateau, D., Chapon, F., Tome, F., Dupret, J. M., et al. (1998). A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet, 20, 92-95.
74. Fu, L., Liang, J. J. (2002). Conformational change and destabilization of cataract gammaC-crystallin T5P mutant. FEBS Lett, 513, 213-216.
75. Liang, J. J. (2004). Interactions and chaperone function of alphaA-crystallin with T5P gammaC-crystallin mutant. Protein Sci, 13, 2476-2482.
76. Piatigorsky, J. (1998). Gene sharing in lens and cornea: facts and implications. Prog Retin Eye Res, 17, 145-174.
77. Bloemendal, H., de Jong, W. W. (1991). Lens proteins and their genes. Prog Nucleic Acid Res Mol Biol, 41, 259-281.
78. Horwitz, J. (2003). Alpha-crystallin. Exp Eye Res, 76, 145-153.
79. Siezen, R. J., Berger, H. (1978). The quaternary structure of bovine alpha-crystallin: size and shape studies by sedimentation, small-angle x-ray scattering and quasielastic light scattering. Eur J Biochem, 91, 397-405.
80. Veretout, F., Delaye, M., Tardieu, A. (1989). Molecular basis of eye lens transparency: osmotic pressure and x-ray analysis of alpha-crystallin solutions. J Mol Biol, 205, 713-728.
81. Bhat, S. P., Nagineni, C. N. (1989). Alpha B subunit of lens-specific protein alphacrystallin is present in other ocular and non-ocular tissues. Biochem Biophys Res Commun, 158, 319-325.
82. Kim, K. K., Kim, R., Kim, S. H. (1998). Crystal structure of a small heat-shock protein. Nature, 394, 595-599.
83. van Montfort, R. L., Basha, E., Friedrich, K. L., Slingsby, C., Vierling, E. (2001). Crystal structure and assembly of a eukaryotic small heat shock protein. Nat Struct Biol, 8, 1025-1030.
84. Stamler, R., Kappe, G., Boelens, W., Slingsby, C. (2005). Wrapping the alphacrystallin domain fold in a chaperone assembly. J Mol Biol, 353, 68-79.
85. Haley, D. A., Bova, M. P., Huang, Q. L., McHaourab, H. S., Stewart, P. L. (2000). Small heat-shock protein structures reveal a continuum from symmetric to variable assemblies. J Mol Biol, 298, 261-272.
86. Haley, D. A., Horwitz, J., Stewart, P. L. (1998). The small heat-shock protein, alphaB-crystallin, has a variable quaternary structure. J Mol Biol, 277, 27-35.
87. Horwitz, J. (1992). Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci U S A, 89, 10449-10453.
88. Rao, P. V., Huang, Q. L., Horwitz, J., Zigler, J. S., Jr. (1995). Evidence that alphacrystallin prevents non-specific protein aggregation in the intact eye lens. Biochim Biophys Acta, 1245, 439-447.
89. Derham, B. K., Harding, J. J. (1999). Alpha-crystallin as a molecular chaperone. Prog Retin Eye Res, 18, 463-509.
90. Horwitz, J., Bova, M. P., Ding, L. L., Haley, D. A., Stewart, P. L. (1999). Lens alpha-crystallin: function and structure. Eye, 13(Pt 3b), 403-408.
91. Clark, J. I., Muchowski, P. J. (2000). Small heat-shock proteins and their potential role in human disease. Curr Opin Struct Biol, 10, 52-59.
92. Brady, J. P., Garland, D., Duglas-Tabor, Y., Robison, W. G., Jr., Groome, A., Wawrousek, E. F. (1997). Targeted disruption of the mouse alpha A-crystallin gene induces cataract and cytoplasmic inclusion bodies containing the small heat shock protein alpha B-crystallin. Proc Natl Acad Sci U S A, 94, 884-889.
93. Wistow, G., Turnell, B., Summers, L., Slingsby, C., Moss, D., Miller, L., Lindley, P., Blundell, T. (1983). X-ray analysis of the eye lens protein gamma-II crystallin at 1.9 A ° resolution. J Mol Biol, 170, 175-202.
94. Piatigorsky, J., Wistow, G. (1991). The recruitment of crystallins: new functions precede gene duplication. Science, 252, 1078-1079.
95. Norledge, B. V., Mayr, E. M., Glockshuber, R., Bateman, O. A., Slingsby, C., Jaenicke, R., Driessen, H. P. (1996). The x-ray structures of two mutant crystallin domains shed light on the evolution of multi-domain proteins. Nat Struct Biol, 3, 267-274.
96. Slingsby, C., Bateman, O. A. (1990). Quaternary interactions in eye lens betacrystallins: basic and acidic subunits of beta-crystallins favor heterologous association. Biochemistry, 29, 6592-6599.
97. Lampi, K. J., Oxford, J. T., Bachinger, H. P., Shearer, T. R., David, L. L., Kapfer, D. M. (2001). Deamidation of human beta B1 alters the elongated structure of the dimer. Exp Eye Res, 72, 279-288.
98. Bax, B., Lapatto, R., Nalini, V., Driessen, H., Lindley, P. F., Mahadevan, D., Blundell, T. L., Slingsby, C. (1990). X-ray analysis of beta B2-crystallin and evolution of oligomeric lens proteins. Nature, 347, 776-780.
99. Norledge, B. V., Hay, R. E., Bateman, O. A., Slingsby, C., Driessen, H. P. (1997). Towards a molecular understanding of phase separation in the lens: a comparison of the x-ray structures of two high Tc gamma-crystallins, gammaE and gammaF, with two low Tc gamma-crystallins, gammaB and gammaD. Exp Eye Res, 65, 609-630.
100. Rudolph, R., Siebendritt, R., Nesslauer, G., Sharma, A. K., Jaenicke, R. (1990). Folding of an all-beta protein: independent domain folding in gamma II-crystallin from calf eye lens. Proc Natl Acad Sci USA, 87, 4625-4629.
101. Pande, J., McDermott, M. J., Callender, R. H., Spector, A. (1991). The calf gamma crystallins: a Raman spectroscopic study. Exp Eye Res, 52, 193-197.
102. Mayr, E. M., Jaenicke, R., Glockshuber, R. (1997). The domains in gammaBcrystallin: identical fold-different stabilities. J Mol Biol, 269, 260-269.
103. Wenk, M., Herbst, R., Hoeger, D., Kretschmar, M., Lubsen, N. H., Jaenicke, R. (2000). Gamma S-crystallin of bovine and human eye lens: solution structure, stability and folding of the intact two-domain protein and its separate domains. Biophys Chem, 86, 95-108.
104. Tardieu, A., Veretout, F., Krop, B., Slingsby, C. (1992). Protein interactions in the calf eye lens: interactions between beta-crystallins are repulsive whereas in gammacrystallins they are attractive. Eur Biophys J, 21, 1-12.
105. Siezen, R. J., Thomson, J. A., Kaplan, E. D., Benedek, G. B. (1987). Human lens gamma-crystallins: isolation, identification, and characterization of the expressed gene products. Proc Natl Acad Sci U S A, 84, 6088-6092.
106. Harding, J. J., Crabbe, M. J.C. (1984). The lens: development, proteins, metabolism, and cataract. In The Eye, Vol. 1B (Dawson, H., (Ed.), Academic Press, London, pp. 207-492.
107. Wistow, G., Wyatt, K., David, L., Gao, C., Bateman, O., Bernstein, S., Tomarev, S., Segovia, L., Slingsby, C., Vihtelic, T. (2005). GammaN-crystallin and the evolution of the betagamma-crystallin superfamily in vertebrates. FEBS J, 272, 2276-2291,
108. Das, K. P., Petrash, J. M., Surewicz, W. K. (1996). Conformational properties of substrate proteins bound to a molecular chaperone alpha-crystallin. J Biol Chem, 271, 10449-10452.
109. Hay, R. E., Andley, U. P., Petrash, J. M. (1994). Expression of recombinant bovine gamma B-, gamma C-and gamma D-crystallins and correlation with native proteins. Exp Eye Res, 58, 573-584.
110. Skouri-Panet, F., Bonnete, F., Prat, K., Bateman, O. A., Lubsen, N. H., Tardieu, A. (2001). Lens crystallins and oxidation: the special case of gammaS. Biophys Chem, 89, 65-76.
111. Lapko, V. N., Smith, D. L., Smith, J. B. (2002). S-methylated cysteines in human lens gamma S-crystallins. Biochemistry, 41, 14645-14651.
112. Takemoto, L., Boyle, D. (2000). Specific glutamine and asparagine residues of gamma-S crystallin are resistant to in vivo deamidation. J Biol Chem, 275, 26109-26112,
113. Takemoto, L., Fujii, N., Boyle, D. (2001). Mechanism of asparagine deamidation during human senile cataractogenesis. Exp Eye Res, 72, 559-563.
114. Loster, J., Pretsch, W., Sandulache, R., Schmitt-John, T., Lyon, M. F., Graw, J. (1994). Close linkage of the dominant cataract mutations (Cat-2) with Idh-1 and cryge on mouse chromosome 1. Genomics, 23, 240-242.
115. Sandilands, A., Hutcheson, A. M., Long, H. A., Prescott, A. R., Vrensen, G., Loster, J., Klopp, N., Lutz, R. B., Graw, J., Masaki, S., et al. (2002). Altered aggregation properties of mutant gamma-crystallins cause inherited cataract. EMBO J, 21, 6005-6014.
116. Flaugh, S. L., Kosinski-Collins, M. S., King, J. (2005). Contributions of hydrophobic domain interface interactions to the folding and stability of human gammaD-crystallin. Protein Sci, 14, 569-581.
117. Mills, I. A., Flaugh, S. L., Kosinski-Collins, M. S., King, J. A. (2007). Folding and stability of the isolated Greek key domains of the long-lived human lens proteins gammaD-crystallin and gammaS-crystallin. Protein Sci, 16, 2427-2444.
118. Kim, Y. H., Kapfer, D. M., Boekhorst, J., Lubsen, N. H., Bachinger, H. P., Shearer, T. R., David, L. L., Feix, J. B., Lampi, K. J. (2002). Deamidation, but not truncation, decreases the urea stability of a lens structural protein, betaB1-crystallin. Biochemistry, 41, 14076-14084.
119. Trinkl, S., Glockshuber, R., Jaenicke, R. (1994). Dimerization of beta B2-crystallin: the role of the linker peptide and the N-and C-terminal extensions. Protein Sci, 3, 1392-1400.
120. Werten, P. J., Carver, J. A., Jaenicke, R., de Jong, W.W.(1996).The elusive role of the N-terminal extension of beta A3-and beta A1-crystallin. Protein Eng, 9, 1021-1028.
121. Bateman, O. A., Sarra, R., van Genesen, S. T., Kappe, G., Lubsen, N. H., Slingsby, C. (2003). The stability of human acidic beta-crystallin oligomers and hetero-oligomers. Exp Eye Res, 77, 409-422.
122. Sun, T. X., Liang, J. J. (1998). Intermolecular exchange and stabilization of recombinant human alphaA-and alphaB-crystallin. J Biol Chem, 273, 286-290.
123. Lampi, K. J., Amyx, K. K., Ahmann, P., Steel, E. A. (2006). Deamidation in human lens betaB2-crystallin destabilizes the dimer. Biochemistry, 45, 3146-3153.
124. Das, B. K., Liang, J. J. (1998). Thermodynamic and kinetic characterization of calf lens gammaF-crystallin. Int J Biol Macromol, 23, 191-197.
125. Jaenicke, R., Slingsby, C. (2001). Lens crystallins and their microbial homologs: structure, stability, and function. Crit Rev Biochem Mol Biol, 36, 435-499.
126. Ghelis, C., Yon, J. (1982). Physicochemical studies of the unfolding-folding equilibrium. In Protein Folding (Horecker, B., Kaplan, N. O., Marmur, J., Scheraga, H.,Eds.), Academic Press, New York.
127. Jaenicke, R. (1999). Stability and folding of domain proteins. Prog Biophys Mol Biol, 71, 155-241.
128. Basak, A., Bateman, O., Slingsby, C., Pande, A., Asherie, N., Ogun, O., Benedek, G. B., Pande, J. (2003). High-resolution x-ray crystal structures of human gammaD crystallin (1.25 A) and the R58H mutant (1.15 A ° ) associated with aculeiform cataract. J Mol Biol, 328, 1137-1147.
129. Flaugh, S. L., Mills, I. A., King, J. (2006). Glutamine deamidation destabilizes human gammaD-crystallin and lowers the kinetic barrier to unfolding. J Biol Chem, 281, 30782-30793.
130. Kim, P. S., Baldwin, R. L. (1984). A helix stop signal in the isolated S-peptide of ribonuclease A. Nature, 307, 329-334.
131. Kim, P. S., Baldwin, R. L. (1990). Intermediates in the folding reactions of small proteins. Annu Rev Biochem, 59, 631-660.
132. Muchowski, P. J., Clark, J. I. (1998). ATP-enhanced molecular chaperone functions of the small heat shock protein human alphaB crystallin. Proc Natl Acad Sci U S A, 95, 1004-1009.
133. Cobb, B. A., Petrash, J. M. (2002). alpha-Crystallin chaperone-like activity and membrane binding in age-related cataracts. Biochemistry, 41, 483-490.
134. Andley, U. P., Mathur, S., Griest, T. A., Petrash, J. M. (1996). Cloning, expression, and chaperone-like activity of human alphaA-crystallin. J Biol Chem, 271, 31973-31980.
135. Das, K. P., Choo-Smith, L. P., Petrash, J. M., Surewicz, W. K. (1999). Insight into the secondary structure of non-native proteins bound to a molecular chaperone alpha-crystallin: an isotope-edited infrared spectroscopic study. J Biol Chem, 274, 33209-33212.
136. Ellis, R. J., van der Vies, S. M. (1991). Molecular chaperones. Annu Rev Biochem, 60, 321-347.
137. Horwich, A. L., Low, K. B., Fenton, W. A., Hirshfield, I. N., Furtak, K. (1993). Folding in vivo of bacterial cytoplasmic proteins: role of GroEL. Cell, 74, 909-917.
138. Leroux, M. R., Hartl, F. U. (2000). Cellular functions of molecular chaperones. In Frontiers in Molecular Biology: Mechanisms of Protein Folding, 2nd ed. (Pain R. H., Ed.), Oxford University Press, New York, pp. 364-405.
139. Hartl, F. U., Hayer-Hartl, M. (2002). Molecular chaperones in the cytosol: from nascent chain to folded protein. Science, 295, 1852-1858.
140. Leroux, M. R., Melki, R., Gordon, B., Batelier, G., Candido, E. P. (1997). Structure-function studies on small heat shock protein oligomeric assembly and interaction with unfolded polypeptides. J Biol Chem, 272, 24646-24656.
141. Sathish, H. A., Koteiche, H. A., McHaourab, H. S. (2004). Binding of destabilized betaB2-crystallin mutants to alpha-crystallin: the role of a folding intermediate. J Biol Chem, 279, 16425-16432.
142. Boyle, D., Takemoto, L. (1994). Characterization of the alpha-gamma and alphabeta complex: evidence for an in vivo functional role of alpha-crystallin as a molecular chaperone. Exp Eye Res, 58, 9-15.
143. Soto, C., Kindy, M. S., Baumann, M., Frangione, B. (1996). Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun, 226, 672-680.
144. Ono, K., Hasegawa, K., Naiki, H., Yamada, M. (2004). Curcumin has potent antiamyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res, 75, 742-750.
145. Ono, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., Yamada, M. (2003). Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J Neurochem, 87, 172-181.
146. Harding, J. J. (2002). Viewing molecular mechanisms of ageing through a lens. Ageing Res Rev, 1, 465-479.
147. Gupta, R., Srivastava, O. P. (2004). Deamidation affects structural and functional properties of human alphaA-crystallin and its oligomerization with alphaBcrystallin. J Biol Chem, 279, 44258-44269.
148. Gupta, R., Srivastava, O. P. (2004). Effect of deamidation of asparagine 146 on functional and structural properties of human lens alphaB-crystallin. Invest Ophthalmol Vis Sci, 45, 206-214.
149. Harms, M. J., Wilmarth, P. A., Kapfer, D. M., Steel, E. A., David, L. L., Bachinger, H. P., Lampi, K. J. (2004). Laser light-scattering evidence for an altered association of beta B1-crystallin deamidated in the connecting peptide. Protein Sci, 13, 678-686.
150. Groenen, P. J., Merck, K. B., de Jong, W. W., Bloemendal, H. (1994). Structure and modifications of the junior chaperone alpha-crystallin: from lens transparency to molecular pathology. Eur J Biochem, 225, 1-19.
151. Zhang, Z., Smith, D. L., Smith, J. B. (2003). Human beta-crystallins modified by backbone cleavage, deamidation and oxidation are prone to associate. Exp Eye Res, 77, 259-272.
152. Broide, M. L., Berland, C. R., Pande, J., Ogun, O., Benedek, G. B. (1991). Binaryliquid phase separation of lens protein solutions. Proc Natl Acad Sci U S A, 88, 5660-5664.
153. Clark, J. I., Clark, J. M. (2000). Lens cytoplasmic phase separation. Int Rev Cytol, 192, 171-187.
154. Liu, C., Asherie, N., Lomakin, A., Pande, J., Ogun, O., Benedek, G. B. (1996). Phase separation in aqueous solutions of lens g-crystallins: special role of gS. Proc Natl Acad Sci U S A, 93, 377-382.
155. Liu, C., Pande, J., Lomakin, A., Ogun, O., Benedek, G. B. (1998). Aggregation in aqueous solutions of bovine lens g-crystallins: special role of gS. Invest Ophthalmol Vis Sei, 39, 1609-1619.
156. Bron, A. J., Vrensen, G. F.J. M., Koretz, J., Maraini, G., Harding, J. J. (2000). The ageing lens. Ophthalmologica, 214, 86-104.
157. Reddy, G. B., Das, K. P., Petrash, J. M., Surewicz, W. K. (2001). Temperaturedependent chaperone activity and structural properties of human aA-and aBcrystallins. J Biol Chem, 275, 4560-4570.
158. Linetsky, M., Hill, J. M.W., Chemoganskiy, V. G., Hu, F., Ortwerth, B. J. (2003). Studies on the mechanism of the UVA light-dependent loss of glutathione reductase activity in human lenses. Invest Ophthalmol Vis Sci, 44, 3920-3926.
159. Haase-Pettingell, C. A., King, J. (1988). Formation of aggregates from a thermolabile in vivo folding intermediate in P22 tailspike maturation: a model for inclusion body formation. J Biol Chem, 263, 4977-4983.
160. Speed, M. A., Wang, D. I., King, J. (1996). Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition. Nat Biotechnol, 14, 1283-1287.
161. Speed, M. A., Morshead, T., Wang, D. I., King, J. (1997). Conformation of P22 tailspike folding and aggregation intermediates probed by monoclonal antibodies. Protein Sci, 6, 99-108.
162. Colon, W., Kelly, J. W. (1992). Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry, 31, 8654-8660.
163. Sunde, M., Blake, C. (1997). The structure of amyloid fibrils by electron microscopy and x-ray diffraction. Adv Protein Chem, 50, 123-159.
164. Li, J., Uversky, V. N., Fink, A. L. (2001). Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry, 40, 11604-11613.
165. Lashuel, H. A., Lai, Z., Kelly, J. W. (1998). Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation. Biochemistry, 37, 17851-17864.
166. Harper, J. D., Lansbury, P. T., Jr. (1997). Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem, 66, 385-407.
167. Liu, Y., Eisenberg, D. (2002). 3D domain swapping: as domains continue to swap. Protein Sci, 11, 1285-1299.
168. Knaus,K. J., Morillas, M., Swietnicki, W., Malone,M., Surewicz, W. K., Yee, V. C. (2001). Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol, 8, 770-774.
169. Carrell, R. W., Lomas, D. A. (1997). Conformational disease. Lancet, 350, 134-138.
170. Mills-Henry, I. A. R. (2007). Stability, unfolding and aggregation of the gamma D and gamma S humen eye crystallins. In Biology, Vol. Ph. D., Massachusetts Institute of Technology, Cambridge, MA.
171. Muchowski, P. J., Valdez, M. M., Clark, J. I. (1999). AlphaB-crystallin selectively targets intermediate filament proteins during thermal stress. Invest Ophthalmol Vis Sci, 40, 951-958.
172. Liu, B. F., Liang, J. J. (2007). Confocal fluorescence microscopy study of interaction between lens MIP26/AQP0 and crystallins in living cells. J Cell Biochem, 104, 51-58.
173. Zhao, H. R., Nagaraj, R. H., Abraham, E. C. (1997). The role of alphaand epsilon-amino groups in the glycation-mediated cross-linking of gammaBcrystallin. Study of three site-directed mutants. J Biol Chem, 272, 14465-14469.
174. Chellan, P., Nagaraj, R. H. (2001). Early glycation products produce pentosidine cross-links on native proteins: novel mechanism of pentosidine formation and propagation of glycation. J Biol Chem, 276, 3895-3903.
175. Stevens, A. (1998). The contribution of glycation to cataract formation in diabetes. J Am Optom Assoc, 69, 519-530.
176. Quinlan, R., Prescott, A. (2004). Lens cell cytoskeleton. In Development of the Ocular Lens (Lovicu, F. J., Robinson, M. L., Eds.). Cambridge University Press, Cambridge, UK, pp. 173-187.
177. Perng, M. D., Quinlan, R. A. (2005). Seeing is believing! The optical properties of the eye lens are dependent upon a functional intermediate filament cytoskeleton. Exp Cell Res, 305, 1-9.
178. Perng, M. D., Zhang, Q., Quinlan, R. A. (2007). Insights into the beaded filament of the eye lens. Exp Cell Res, 313, 2180-2188.
179. Quinlan, R. A., Sandilands, A., Procter, J. E., Prescott, A. R., Hutcheson, A. M., Dahm, R., Gribbon, C., Wallace, P., Carter, J. M. (1999). The eye lens cytoskeleton. Eye, 13(Pt 3b), 409-416.
180. Beebe, D. C., Cerrelli, S. (1989). Cytochalasin prevents cell elongation and increases potassium efflux from embryonic lens epithelial cells: implications for the mechanism of lens fiber cell elongation. Lens Eye Toxic Res, 6, 589-601.
181. Lonchampt, M. O., Laurent, M., Courtois, Y., Trenchev, P., Hughes, R. C. (1976). Microtubules and microfilaments of bovine lens epithelial cells: electron microscopy and immunofluorescence staining with specific antibodies. Exp Eye Res, 23, 505-518.
182. Herrmann, H., Aebi, U. (2000). Intermediate filaments and their associates: multitalented structural elements specifying cytoarchitecture and cytodynamics. Curr Opin Cell Biol, 12, 79-90.
183. Merdes, A., Brunkener, M., Horstmann, H., Georgatos, S. D. (1991). Filensin: a new vimentin-binding, polymerization-competent, and membrane-associated protein of the lens fiber cell. J Cell Biol, 115, 397-410.
184. FitzGerald, P. G. (1988). Immunochemical characterization of a Mr 115 lens fiber cell-specific extrinsic membrane protein. Curr Eye Res, 7, 1243-1253.
185. Hess, J. F., Casselman, J. T., FitzGerald, P. G. (1993). cDNA analysis of the 49 kDa lens fiber cell cytoskeletal protein: a new, lens-specific member of the intermediate filament family? Curr Eye Res, 12, 77-88.
186. Merdes, A., Gounari, F., Georgatos, S. D. (1993). The 47-kD lens-specific protein phakinin is a tailless intermediate filament protein and an assembly partner of filensin. J Cell Biol, 123, 1507-1516.
187. Jakobs, P. M., Hess, J. F., FitzGerald, P. G., Kramer, P., Weleber, R. G., Litt, M. (2000). Autosomal-dominant congenital cataract associated with a deletion mutation in the human beaded filament protein gene BFSP2. Am J Hum Genet, 66, 1432-1436.
188. Conley, Y. P., Erturk, D., Keverline, A., Mah, T. S., Keravala, A., Barnes, L. R., Bruchis, A., Hess, J. F., FitzGerald, P. G., Weeks, D. E., et al. (2000). A juvenileonset, progressive cataract locus on chromosome 3q21-q22 is associated with a missense mutation in the beaded filament structural protein-2. Am J Hum Genet, 66, 1426-1431.
189. Lo, W. K., Shaw, A. P., Paulsen, D. F., Mills, A. (2000). Spatiotemporal distribution of zonulae adherens and associated actin bundles in both epithelium and fiber cells during chicken lens development. Exp Eye Res, 71, 45-55.
190. Robinson, K. R., Patterson, J. W. (1982). Localization of steady currents in the lens. Curr Eye Res, 2, 843-847.
191. Kistler, J., Eckert, R., Donaldson, P. (2004) Lens cell membranes. In Development of the Ocular Lens (Lovicu, F. J., Robinson, M. L., Eds.), Cambridge University Press, Cambridge, UK, pp. 151-173.
192. Lin, J. S., Eckert, R., Kistler, J., Donaldson, P. (1998). Spatial differences in gap junction gating in the lens are a consequence of connexin cleavage. Eur J Cell Biol, 76, 246-250.
193. Reddy, M. A., Francis, P. J., Berry, V., Bhattacharya, S. S., Moore, A. T. (2004). Molecular genetic basis of inherited cataract and associated phenotypes. Surv Ophthalmol, 49, 300-315.
194. Jaenicke, R., Slingsby, C. (2001). Lens crystallins and their microbial homologs: structure, stability, and function. Crit Rev Biochem Mol Biol, 36, 435-499.